Texting Platform for Recurrent UTIs
(Urotrust Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI).The main question it aims to answer is:• can a texting platform that integrates symptom triage and prevention education reduce the rate of unnecessary antibiotics for recurrent UTIs as compared to usual care?Participants enrolled onto the texting platform will:• receive evidence-based clinical guidance for the management of symptoms of UTI and receive educational videos on how to prevent UTIs. An important secondary outcome is to determine if the texting platform improves self-efficacy for the management of recurrent UTI.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are on continuous suppressive antibiotics, you cannot participate.
How is the EHR-integrated rUTI Texting Platform treatment different from other treatments for recurrent UTIs?
The EHR-integrated rUTI Texting Platform is unique because it uses a texting system to help manage recurrent urinary tract infections by integrating with electronic health records (EHR) to provide personalized support and preventive strategies, unlike traditional treatments that primarily focus on medication.12345
What data supports the effectiveness of the treatment EHR-integrated rUTI Texting Platform for recurrent UTIs?
Are You a Good Fit for This Trial?
This trial is for women over 18 with recurrent UTIs who can give informed consent, follow the study procedures, and have a mobile device that can text. They must be able to read/write English but cannot join if they have urinary system anomalies, certain bladder conditions, recent pregnancy, uncontrolled diabetes or are on specific medications.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive evidence-based clinical guidance and educational videos for managing recurrent UTIs via a texting platform
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- EHR-integrated rUTI Texting Platform
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Independence Blue Cross
Collaborator